News & Events

Generations of Yale physicians have treated patients and launched cutting-edge health care initiatives through Yale’s affiliation with the VA Connecticut Healthcare System.

In a new study published in JAMA Network Open, Yale researchers examined the burdens for people who use public transit to access methadone treatment for opioid use disorder (OUD) at Opioid Treatment Programs (OTPs) in Connecticut.

A new study from Yale School of Medicine researchers found a positive link between chronic hepatitis C and pancreatic cancer. The study, which was published in JAMA Network Open, revealed that individuals with chronic HCV infection have a 1.8-fold increased risk of pancreatic cancer compared to those who test negative for the virus.

Yale will launch the Aging Well With HIV Through Alcohol Research and Risk Reduction and Education (AWAR3E) Center with a five-year grant awarded by the National Institute on Alcohol Abuse and Alcoholism.

A new collaborative program, the Ugandan Registry of RMDs in HIV (GEMINI), aims to improve the study of HIV and rheumatic and musculoskeletal diseases (RMDs) in Uganda.

A new Yale-led retrospective cohort study published in Drug and Alcohol Dependence examined the efficacy of a range of treatments for patients who survived an opioid overdose and identified treatments that are most successful in preventing subsequent overdoses.

Amy C. Justice, MD, PhD, C.N.H. Long Professor of Medicine (General Medicine) at Yale School of Medicine, professor of public health (health policy) at the Yale School of Public Health, and staff physician at the West Haven VA Medical Center, received the 2025 John M. Eisenberg National Award for Career Achievement in Research from the Society of General Internal Medicine (SGIM).

Emma Biegacki, MPH, program manager in the Section of General Internal Medicine, and Denise Brennan, medical coordinator in Medical Education, were honored with the 2025 Department of Internal Medicine Service Excellence Award at the Internal Medicine Staff Town Hall on April 30, 2025.

Meet Basile Njei, MD, MPH, PhD, assistant professor of medicine (digestive diseases). Njei is combining genetics and artificial intelligence (AI) to improve clinical outcomes, detect liver disease, and identify genetic and clinical predictors of liver disease. Njei is currently the co-director of the International Medicine Program in the Section of Digestive Diseases, through which he collaborates with the U.S. embassy in Cameroon to improve medical education and integrate AI into health care in Africa.